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Introduction {#sec1}
============

BK polyomavirus (BKV) is an opportunistic pathogen that causes severe diseases in the immunosuppressed ([@bib5]). Initial infection may occur through a respiratory or oral route, and is either asymptomatic or causes a mild respiratory illness ([@bib16]). A persistent infection is then established in the kidney and urinary tract, and 80%--90% of the general population are thought to be seropositive for the most prevalent BKV genotypes ([@bib3], [@bib10], [@bib28], [@bib60]). In patients undergoing immunosuppression following kidney or bone marrow transplantation, lytic replication can occur, causing polyomavirus-associated nephropathy (PVAN) and hemorrhagic cystitis ([@bib38], [@bib5], [@bib2]). Up to 10% of kidney transplant patients experience PVAN, with as many as 90% of these eventually losing their graft ([@bib50]). The prevalence of BKV-associated disease is rising as the number of transplants increases ([@bib5]), and there is also mounting evidence that BKV, similar to Merkel cell polyomavirus, may be carcinogenic in humans ([@bib39], [@bib34], [@bib47], [@bib36], [@bib13], [@bib61], [@bib12]). No effective antivirals specifically targeting BKV are available ([@bib5], [@bib2]), and so there is increasing interest in the development of targeted therapeutics. High-resolution structural information for the infectious BKV virion and its interaction with cellular receptors would be a useful resource in designing and evaluating such therapies.

Our current understanding of polyomavirus structure comes largely from pioneering work by Caspar ([@bib17], [@bib52]) and Harrison ([@bib57], [@bib59], [@bib33]) on SV40 (which infects Rhesus monkeys), and murine polyomavirus (PyV). Crystal structures revealed that polyomavirus capsids consist of 360 copies of the major capsid protein VP1, which form 72 "pentons," each consisting of a ring of five β barrel-containing VP1 monomers ([@bib45]). Together, these form a *T* = 7d lattice, with a C-terminal arm from each VP1 making interactions with neighboring pentons to stabilize the capsid shell. Essentially, polyomaviruses position pentameric capsomers in what would be the pentavalent and hexavalent positions of a true quasi-equivalent lattice ([@bib19], [@bib7]). The asymmetric unit of these capsids therefore comprises six quasi-equivalent VP1 chains, five of which form the pentons in a hexavalent position, with the remaining VP1 chain from five asymmetric units occupying a pentavalent position. A single copy of the minor capsid protein VP2, or its N-terminal truncated variant VP3, is incorporated within each penton ([@bib9], [@bib22]).

Subsequently, there has been a shift toward using isolated VP1 pentons for both structural and functional studies. Binding experiments using such pentons, which cannot assemble into virus-like particles (VLPs), indicated that binding of free pentons to cells requires the presence of sialylated glycans on the host cell membrane ([@bib37], [@bib40]). Crystallographic structures of putative receptor ligands soaked into penton crystals have revealed the molecular mechanisms of receptor recognition ([@bib43], [@bib41], [@bib40], [@bib42], [@bib58]). However, the major BKV receptors GD1b and GT1b ([@bib35]) cannot be soaked into crystals, presumably as a result of steric restrictions ([@bib40]). Furthermore, crystallization of isolated pentons requires the removal of the N and C termini of VP1. Therefore, such structures do not allow us to understand how receptors are engaged by the native virion, and penton structures may not capture the full range of surface features which could be targeted by therapeutics. Indeed, recent reports suggest BKV VLPs, but not pentons, can use glycosaminoglycans (GAGs) to attach to target cells ([@bib15]), suggesting that GAGs bind in regions where different capsomers interact, which are missing from capsomer structures. Cryoelectron microscopy (cryo-EM) is potentially well suited to determining the structures of intact virion:receptor complexes, but no EM structure to date has sufficient resolution to elucidate the interactions stabilizing the polyomavirus capsid, or to identify bound ligands (current structures range from 8 to 25 Å \[[@bib22], [@bib32], [@bib45], [@bib56], [@bib17]\]).

Here, we use high-resolution cryo-EM to determine the structure of BKV at 3.8 Å resolution. This resolution allows us to highlight differences between this human pathogen and those that infect simian and murine hosts, which include differences in how both the C-terminal arms and disulfide bonding stabilize the capsid. The importance of disulfide bonds is confirmed by a lower-resolution structure of BKV in reducing conditions in which the density we ascribe to disulfide bonds disappears. We also use a simple method analogous to crystallographic soaking, to determine the structures of BKV bound to receptors: the oligosaccharide moiety of ganglioside GT1b (at 3.4 Å resolution) and the model GAG heparin (at 3.6 Å resolution). Neither receptor causes a conformational change in the capsid, presumably functioning cooperatively to increase the avidity of attachment to the host cell surface.

Results {#sec2}
=======

The High-Resolution Structure of BKV:Receptor Complexes {#sec2.1}
-------------------------------------------------------

BKV is difficult to concentrate to the levels required for optimal cryo-EM data collection, so to increase the particle concentration and distribution of BKV for cryo-EM studies, multiple aliquots of purified virions were applied to lacey carbon grids overlaid with a layer of continuous carbon ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Owing to the low concentration of our virus samples and low affinity of polyomavirus:receptor interactions (∼1--5 mM) ([@bib44], [@bib59]), to study the BKV:GT1b structure we implemented an on-grid soaking protocol, where a 20 mM solution of the oligosaccharide portion of GT1b was applied to the carbon-immobilized virions for 30 s prior to blotting and plunge freezing ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Collectively, these approaches allowed us to determine the structure of native BKV at 3.8 Å resolution ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A), and in complex with the oligosaccharide moiety of GT1b at 3.4 Å resolution ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B). The BKV and BKV:GT1b structures are essentially identical, other than the presence of extra, high-resolution density on the capsid surface corresponding to the oligosaccharide portion of GT1b (see below).Figure 1The Structures of BKV and BKV:GT1b(A) Isosurface representation of the 3.8 Å structure of BKV viewed down the icosahedral 2-fold and colored according to the radial coloring scheme shown.(B) Isosurface representation of the 3.4 Å structure of BKV, in complex with GT1b (magenta). Representative EM density containing the refined atomic model is shown below each respective structure to highlight the quality of the maps.

As expected, the BKV capsid has a *T* = 7d quasi-symmetry, and is built from 72 pentons of the major capsid protein VP1 ([Figure 2](#fig2){ref-type="fig"}A). Each of the six distinct conformations of VP1 present within the asymmetric unit of the capsid shares a common core fold ([Figures 2](#fig2){ref-type="fig"}B/2C), which is the β sandwich, "jelly roll" fold, characteristic of many viral capsid proteins. The C-terminal arms, which invade adjacent capsomers to build the capsid, are well-resolved, and at a slightly lower resolution than the VP1 core (on average ∼0.2 Å poorer; [Figure S2](#mmc1){ref-type="supplementary-material"}). The resolution of our map was sufficient to identify part of the shared C terminus of VP2 and VP3, corresponding to residues 288--301 in the VP2 sequence ([Figures 2](#fig2){ref-type="fig"}D and 2E). While all pentons contain symmetry-averaged density for VP2/3 ([@bib22]), only the pentavalent capsomeres contained density into which an atomic model could be built. This density is located at the base of the pentons as described previously for an isolated VP1 penton from PyV ([@bib9]), and describes a small hydrophobic helix that is highly conserved in the VP2/3 sequences of polyomaviruses. The polypeptide sequence for this modeled region differs by four residues between BKV and PyV, one of which localizes to the hydrophobic helix ([@bib9]). Unlike PyV, there is much less interpretable density toward the N terminus of this region for BKV, perhaps reflecting increased mobility in this solution structure of the intact virion. Beneath the VP2 density (in both BKV and BKV:GT1b structures), we see the same shells of density reported at lower resolution ([@bib22]), but these disappear with map sharpening, suggesting no high-resolution symmetric structure is present for the packaged DNA.Figure 2Atomic Model for the BKV Capsid and Interaction with the Minor Capsid Proteins(A) The *T* = 7d icosahedral model of the BKV capsid viewed down an icosahedral 2-fold axis with each quasi-equivalent VP1 chain colored according to the color key shown.(B) A single asymmetric unit of the capsid showing the conformation of each of the C termini.(C) Overlay of all the VP1 monomers in the asymmetric unit with the most variable regions (N terminus, C terminus, and CD loop) colored according to chain number.(D) Internal view of a 5-fold penton showing the model and EM density (2.2 σ within 1.6 Å of fitted coordinates) for the C-terminal region of VP2/VP3 binding at the base of the two adjacent VP1 monomers (gray).(E) Enlarged view of VP2/VP3 as shown in (D).

Structural Comparison of BKV to the Non-human Polyomavirus SV40 {#sec2.2}
---------------------------------------------------------------

BKV and SV40 share 81.7% sequence identity in their major capsid protein, VP1, so, as expected, the core fold of VP1 is very similar in our BKV structure to that previously seen in SV40. However, we were able to visualize differences in the C-terminal arms of three of the six distinct conformers of VP1.

The biggest change is in chain 6 (gray in [Figures 3](#fig3){ref-type="fig"}A and 3B). In SV40, the electron density is only interpretable to residue Gln^355^, where the polypeptide backbone points away from the virion (i.e., into bulk solution). In BKV, the polypeptide chain adopts a different conformation from Tyr^349^ onward, and in the EM density map this region is well resolved, allowing us to build an additional four residues (up to Lys^359^). This segment is resolved in an extended conformation that makes a series of interactions with an arched structure formed by the C terminus of chain 3 (green in [Figure 3](#fig3){ref-type="fig"}C). This is a significant difference with respect to the conformation seen for SV40, as the conformation reported here is consistent with the formation of up to ten potential additional H-bonding interactions.Figure 3The C Terminus of BKV(A) Atomic model of the 5-fold coordinated pentamer colored as described in [Figure 2](#fig2){ref-type="fig"}.(B) Enlarged view of the C terminus of chain 6 with the equivalent region from SV40 colored black.(C) Enlarged view of the extended conformation shown in (B) showing potential hydrogen bonds between the C terminus of chains 6 and 3 of BKV.(D) Atomic model of two adjacent hexavalent pentamers which make up the icosahedral 2-fold.(E) The symmetry-related C termini of chain 1 indicated by a box in (D), showing the hydrophobic interaction between residues 296--304 with EM density for the sharpened map (3 σ).(F) A single VP1 monomer of chain 1 for BKV showing the equivalent C terminus of SV40 (black).(G) Enlarged view of the possible intra-chain interaction denoted by a box in (F) showing EM density for the sharpened map low-pass filtered to 4 Å (2 σ).

Differences between BKV and SV40 are also observed at the icosahedral 2-fold axes, which are formed at the interface between two adjacent chain 1s, in the region of residues 296--315 ([Figure 3](#fig3){ref-type="fig"}D). In BKV, the EM density is well resolved at the 2-fold axis, allowing us to build a conformation of the chain 1 polypeptide that forms an intimate hydrophobic interface around which the 2-fold axis of the particle is constructed ([Figure 3](#fig3){ref-type="fig"}E). This different conformation also results in a possible intramolecular interaction in BKV between Arg^214^ (Lys in SV40) in the VP1 core and Asn^310^ in the C-terminal arm ([Figures 3](#fig3){ref-type="fig"}F and 3G).

Location of Disulfide Bonds and Ca^2+^ Binding within the BKV Capsid {#sec2.3}
--------------------------------------------------------------------

Polyomavirus capsids are stabilized by Ca^2+^ binding ([@bib45]), and two putative locations for Ca^2+^ binding have been previously identified by the presence of gadolinium ions in heavy metal soaking experiments for crystallographic structure determination of SV40 ([@bib33]). In our solution structures of BKV, we see a single density consistent with a Ca^2+^ ion coordinated by glutamate side chains and the backbone carbonyl of a serine residue ([Figure 4](#fig4){ref-type="fig"}A). This location is consistent with the proposed site 1 in SV40. However, no equivalent density for any metal ion binding at site 2 is present in any of our structures.Figure 4Location of Calcium Ions and Disulfides within the BKV Virion(A) The calcium binding site in the sharpened BKV map with EM density for calcium shown at 6 σ with surrounding residues colored according to the corresponding chain.(B) Atomic model of the CD loops of chains 2, 3, and 6 and the N terminus of an adjacent chain 2 from BKV with EM density shown at 1.5 σ.(C) Density from the unsharpened, non-reduced BKV map low-pass filtered to 7 Å (0.5 σ), showing additional density extending from the N terminus of chain 2 and connecting to the CD loop of an adjacent chain 2.(D) Analogous region to that shown in (C) from the unsharpened reduced BKV map low-pass filtered to 7 Å (0.5 σ).(E) Density from the unsharpened BKV map low-pass filtered to 7 Å (1 σ), showing additional density extending from the N terminus of chain 4 and connecting to the CD loop of chain 1.(F) Analogous region to that shown in (E) from the unsharpened reduced BKV map low-pass filtered to 7 Å (1 σ).

Disulfide bond formation is also critical for capsid stability ([@bib45]), and their reduction/isomerization in the endoplasmic reticulum of an infected host cell appears to be an essential step in virion uncoating ([@bib53], [@bib25]). It has been shown previously that intermolecular disulfide bonds between Cys^104^ residues serve to stabilize the SV40 capsid, and it has been suggested, but not shown, that Cys^9^ may also be involved in disulfide bonding. The presence of Cys residues at position 104 is conserved between BKV and SV40, but the conformations of the CD loops that contain Cys^104^ are different. In SV40, the CD loops of chains 2, 3, and 6 were observed in close proximity at an interface between pentavalent and hexavalent pentons, but that SV40 structure was not able to resolve which pair of chains participated in a disulfide bond ([@bib57]). In BKV, the conformation of the CD loops is different, and strongly suggests that a disulfide bond is formed between the CD loops of chains 3 (green) and 6 (gray). The CD loop of chain 2 (yellow) is orientated away from this interaction ([Figure 4](#fig4){ref-type="fig"}B). In contrast to SV40, in BKV the N terminus of a chain 2 from an adjacent capsomere points toward the chain 2 CD loop. In our sharpened map, we are not able to resolve density for the first 13 residues of chain 2, suggesting this portion of the capsid is less well ordered. However, in the unsharpened map, which retains lower-resolution information, a bridge of density joins the N terminus to the CD loop before turning and continuing toward the encapsidated genome ([Figure 4](#fig4){ref-type="fig"}C). This density is entirely consistent with a Cys^104^-Cys^9^ disulfide bond. A similar bridge of density is observed beneath the icosahedral 2-fold axes where the N terminus of chain 4 bridges to the CD loop of chain 1 ([Figure 4](#fig4){ref-type="fig"}E). As there is no high-resolution density for these interactions, we sought to confirm the presence of Cys^104^-Cys^9^ disulfide bonds by determining the structure of BKV under reducing conditions ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). The resulting structure is less ordered and has poorer resolution (6.5 Å) than the non-reduced structure (3.8 Å), likely reflecting the decreased rigidity of the virion. For direct comparison, the reduced and non-reduced structures were low-pass filtered to 7 Å. Crucially, the density for the Cys^104^-Cys^9^ disulfides are completely absent in the reduced structure ([Figures 4](#fig4){ref-type="fig"}D and 4F).

The Interaction of BKV with GT1b Oligosaccharide {#sec2.4}
------------------------------------------------

GT1b is a branched oligosaccharide, described previously as having "left" and "right" arms ([@bib40]) ([Figure 5](#fig5){ref-type="fig"}F). The disialic acid motif located on the right arm, of GT1b is well resolved in the 3.4 Å map ([Figures 5](#fig5){ref-type="fig"}A and 5B). The binding mode is similar to that seen previously in a structure of GD3, an oligosaccharide that lacks a left arm, bound to a BKV VP1 penton. The left arm of GT1b is poorly resolved in our structure, indicating that it is not ordered at high resolution. To examine the possible location of the GT1b left arm, we emphasized lower-resolution features in the map by applying a 5 Å low-pass filter to the 3.4 Å map. This revealed bridges of density between Asp^59^ and Lys^83^ of VP1 and the GT1b density ([Figure 5](#fig5){ref-type="fig"}C), consistent with previous mutagenesis data of these residues (D59Y and K83A), which resulted in significantly reduced BKV spread in cell culture ([@bib40]). We also performed molecular dynamics simulations on a penton in complex with five GT1b molecules. For direct comparison with the EM density map the 3D density distribution of the GT1b heavy atoms was calculated from the accumulated 5.5 μs simulations ([Figure 5](#fig5){ref-type="fig"}D). A snapshot from this simulation reveals an orientation where Asp^59^ and Lys^83^ could interact with the left arm of GT1b ([Figure 5](#fig5){ref-type="fig"}E). Additional interactions identified during the simulation are shown in [Figure S4](#mmc1){ref-type="supplementary-material"}, and it is evident that the left arm contributes to binding affinity through multiple transient interactions with the BKV surface.Figure 5Interaction of BKV with GT1b and Heparin(A) Isosurface representation of a single 5-fold pentamer of the BKV-GT1b complex with the capsid colored as in [Figure 2](#fig2){ref-type="fig"} and GT1b (magenta).(B) Enlarged view of the GT1b density (2 σ) containing the corresponding atomic model for the disialic acid motif of the right arm, colored as in (D).(C) The 5 Å low-pass-filtered BKV-GT1b EM density (blue mesh) containing the high-resolution information shown in (B).(D) MD-derived atom density map for the simulated structure of GT1b overlaid with the 5 Å low-pass-filtered EM density shown in (C).(E) A snapshot of the MD simulated structure of GT1b showing possible interactions of the left arm with Asp^59^ and Lys^83^.(F) SNFG-representation of GT1b oligosaccharide showing the left and right arms of the molecule ([@bib63]).(G) Isosurface representation of the unsharpened and 8 Å low-pass-filtered BKV-GT1b map viewed down the icosahedral 2-fold axis and colored according to the radial coloring scheme shown (Å). The GT1b difference density (3.4 σ) is shown colored magenta.(H) The unsharpened and 8 Å low-pass-filtered isosurface representation of the BKV-heparin structure, with the putative heparin difference density (3.4 σ) colored orange.

To investigate recent reports of non-sialylated GAGs acting as receptors for BKV infection, we again utilized on-grid binding with the same heparin used in recently published inhibition assays ([Figure S5](#mmc1){ref-type="supplementary-material"}A) ([@bib15]). The final sharpened map had a resolution of 3.6 Å ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C), and again there are no obvious structural differences in the BKV capsid compared with the BKV and BKV:GT1b structures. However, unlike the sharpened BKV-GT1b map, no obvious density for heparin was visible at high resolution. To identify potential low-resolution modes of binding, difference maps were calculated between the low-pass-filtered versions of the maps. The location of the resulting GT1b difference density is in agreement with our model of the branched GT1b molecule ([Figure 5](#fig5){ref-type="fig"}G), while density, which we ascribe to heparin, is located as a smear between the capsomers, and at the top of each capsomer pore ([Figure 5](#fig5){ref-type="fig"}H). The density between the capsomers locates the putative site of heparin binding atop a patch of positive charge on the virion surface ([Figures S5](#mmc1){ref-type="supplementary-material"}D and S5E).

Discussion {#sec3}
==========

The structures of BKV presented here provide a detailed view of a native, infectious, human polyomavirus. The overall architecture of the BKV capsid is essentially the same as previously described for SV40 and PyV. However, the quality and completeness of the cryo-EM structures means that we are able to describe the different conformations of the C termini of VP1 in a particle in solution. The C termini play a fundamental role in the assembly and stability of a polyomavirus capsid, adopting six distinct conformations that allow a single VP1 sequence to adopt all of the positions in a *T* = 7d lattice. It is unclear whether the differences we observe arise from sequence differences between SV40 and BKV or from the different solution conditions of the experiments. It should be noted, however, that the solution structures determined herein, are in more native-like conditions than those used to determine the crystal structures ([@bib31], [@bib59]). So, whether differences arise from experimental conditions or sequence variation, they provide insights into the structure of a human pathogen in near-native conditions. The intersubunit interactions described here ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) have implications for the structure and stability of the virus. The conformation observed for the C terminus of chain 6 ([Figure 3](#fig3){ref-type="fig"}B) suggests that it interacts with a loop of the C-terminal arm of chain 3, generating up to 10 potential H-bonding interactions ([Figure 3](#fig3){ref-type="fig"}C). Given that this interaction occurs 60 times in an intact capsid, this represents a significant source of additional stability for the BKV virion. In addition, amino acid variations between some BKV serotypes map to this region of the C terminus of VP1, indicating a possible role in antigenicity ([@bib48]).

A different conformation is also evident in the C termini of chain 1, which make the 2-fold axes of the BKV and SV40 capsids ([Figures 3](#fig3){ref-type="fig"}D--3G), forming a tighter and more intimate hydrophobic interface. Interestingly, we see additional differences beneath (i.e., at lower radius) this interface. The N terminus of chain 4 and the CD loop of chain 1 appears to make a disulfide bond (Cys^9^-Cys^104^), which would further stabilize the capsid in this region. We are also able to refine the model of how pentavalent and hexavalent pentons are linked by disulfide bonds, as we show that only disulfides between Cys^104^ residues in chains 3 and 6 are present in our structure. Furthermore, previous suggestions that chain 6 might also disulfide bond to chain 2 would not be possible in our structures. The chain 2 CD loop is in a different conformation to that seen in SV40, which allows disulfide bonding to the N terminus of a second chain 2 molecule. These observations allow us to account for the disulfide bonding of all of the CD loops in the structure, and two of the N termini. We therefore present a much more complete picture of disulfide bonding in the capsid. The differences could reflect genuine differences between BKV and SV40, or indicate that the SV40 in the crystals from which the structure was solved was not in a fully oxidized state.

We also present structural data for two different receptors bound to the surface of the virus. In the 3--4 Å resolution range of the structures presented, there is no detectable conformational change in VP1. In our BKV:GT1b structure, we are able to resolve the disialic acid motif of the GT1b right arm to high resolution, confirming a conserved mode of binding between the large B-series gangliosides and smaller variants studied previously. MD simulations show that the left arm of GT1b is dynamic, explaining the lack of high-resolution density in our EM map, and its previous intractability to crystallographic studies. Low-resolution EM density and MD suggest a likely mechanism of binding for the left arm of GT1b, in which multiple, weak interactions occur with the VP1 surface. Such interactions provide the structural correlate to previous mutagenic and functional studies showing that the presence of a left arm enhances infectivity ([@bib40]).

These results demonstrate the emerging role cryo-EM can play in structural glycobiology, to complement existing nuclear magnetic resonance and crystallographic approaches. The ability to produce polyomavirus-ligand structures at resolutions approaching that of X-ray crystallography also leads to the exciting prospect that cryo-EM could be used to study small molecule inhibitors of BK infection or assembly, and indeed the structure of BKV:GT1b presented here is an ideal platform for the *in silico* design of such tool molecules. It is clear that neither GT1b nor GAG binding induce detectable conformational change in the VP1 component of the capsid, and presumably act simply as attachment receptors to facilitate cell entry, where changes in redox state and pH can effect changes in capsid structure that lead to uncoating ([@bib25]).

It is not possible to determine whether the density between pentamers represents bound GAG molecules, but the lack of resolution suggests that no single mode of binding exists. However, this site is positively charged, as are GAG binding sites observed in other viruses ([@bib46], [@bib14]). Density in the pore of each pentamer and at the 2-fold axes would be subject to inappropriate symmetry averaging, and so must be interpreted with great care. The possibility that GAGs bind in the pore of the VP1 pentamer is intriguing however. We see no evidence for an interaction between GAGs and VP2/3, but the pore is directly above their location, and it is interesting to note that BKV pseudoviruses that lack VP2 and VP3 are less efficient at transducing a range of different cell types ([@bib55]), which might be partially explained by a reduced affinity for GAGs. Indeed, the entire VP1 shell is remarkably porous, potentially allowing other opportunities for the interactions between minor capsid proteins and GAGs that have been suggested for a related virus, human papillomavirus 16 ([@bib18]). Our observations provide structural clues about GAG binding to BKV and may form a basis to determine the precise molecular mechanism of GAG interaction using shorter, defined fragments of heparin, which may be more amenable to high-resolution structural characterization. Interestingly GAG analogs have reportedly been used to treat BKV-associated disease ([@bib62], [@bib64], [@bib23], [@bib8]). The rationale for such treatments was based on restoration of the barrier function of the bladder epithelium, but in light of recent results (including those presented here), it is possible that GAGs may bind directly to BKV and perturb cellular attachment or entry.

The rationale for the studies presented here is to inform the design of future anti-BKV therapies. Such therapies could include antibodies capable of neutralizing BKV, or BKV vaccination. Human mAbs which bind BKV virions have recently been reported ([@bib24]), and vaccination with BKV VLPs has been shown to induce pan-specific immunity in mouse models ([@bib48]). Our structures of the native, reduced, and receptor-bound virions provide a platform for understanding such antibody responses to BKV, and features that underpin vaccine stability. Going forward, co-structures with mAbs that show BKV serotype-specific neutralization ([@bib51]), broad cross-neutralization, or non-neutralizing mAbs will be key for guiding efforts to further develop therapies to protect patients against BKV nephropathy ([@bib6]).

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains**PGEM7-Dunlop (BK virus Dunlop strain)Laboratory of Michael Imperiale, University of MichiganN/A**Chemicals, Peptides, and Recombinant Proteins**GT1b oligosaccharideCarboSynthCat\# OO16323HeparinSigmaCat\# 4784**Deposited Data**Density map of BKV in complex with GT1bThis paperElectron Microscopy Data Bank: EMD-3944Density map of BKV in complex with heparinThis paperElectron Microscopy Data Bank: EMD-3945Density map of unliganded BKVThis paperElectron Microscopy Data Bank: EMD-3946Density map of reduced BKVThis paperElectron Microscopy Data Bank: EMD-4212Coordinates for the BKV-GT1b asymmetric unitThis paperPDB: [6ESB](pdb:6ESB){#intref0010}**Experimental Models: Cell Lines**Vero cellsATCCCCL-81 RRID: CVCL_0059**Software and Algorithms**RELION 2.0([@bib26], [@bib54])<https://www2.mrc-lmb.cam.ac.uk/relion>MOTIONCOR2([@bib66])<http://msg.ucsf.edu/em/software/motioncor2.html>gCTF([@bib65])<https://www.mrc-lmb.cam.ac.uk/kzhang/Gctf/>UCSF Chimera([@bib49])<https://www.cgl.ucsf.edu/chimera/> RRID: SCR_004097Coot([@bib11])<https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/> RRID: SCR_014222Phenix([@bib20])<https://www.phenix-online.org/> RRID: SCR_014224PDBePISA([@bib30])<http://www.ebi.ac.uk/pdbe/pisa/> RRID: SCR_015749PyMOL(The PyMOL Molecular Graphics System, Version 2.0, Schrödinger, LLC)<https://pymol.org/> RRID: SCR_000305

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to, and will be fulfilled by, the lead contact, Neil A. Ranson (<n.a.ranson@leeds.ac.uk>).

Method Details {#sec4.3}
--------------

### Cell Culture {#sec4.3.1}

Vero cells were maintained in DMEM with 10% fetal bovine serum (FBS) and 50 U/ml penicillin and streptomycin. Cells were grown at 37°C with 5% CO~2~ in a humidified incubator.

### Virus Growth {#sec4.3.2}

The genome of BKV Dunlop strain (a kind gift from Professor Michael Imperiale, University of Michigan) was prepared as reported previously ([@bib1]). Briefly, the genome was excised from the pGEM7 Dunlop plasmid by *Bam*HI (New England Biolabs) digestion and then recircularized using T4 Ligase (New England Biolabs). Vero cells were seeded into 4 x T75 flasks and transfected with 4 μg DNA using NanoJuice (Novagen) according to the manufacturer\'s instructions with a DNA to Core ratio of 1:2 and DNA to Booster ratio of 1:3. Transfection complexes were removed 16 hr post transfection and replaced with fresh growth media. Ten days post transfection the cells were harvested by scraping into the media and subjected to three rounds of freeze-thaw using liquid N~2~. The crude virus stocks were used to infect 36 x T175 flasks of 50% confluent Vero cells at 37°C; after 2 hr the virus was removed and replaced with fresh growth media.

### Virus Purification {#sec4.3.3}

BKV-infected Vero cells were harvested 21 days post infection and purified essentially as described previously ([@bib56]). Cells were harvested by scraping and pelleted at 4000 x *g* before being resuspended in 10 ml of buffer A (10 mM Tris, 50 mM NaCl, 0.01% Triton X-100) supplemented with an EDTA-free protease inhibitor cocktail (Roche). The lysate was freeze thawed 3 times with 3 min sonication in a water bath between each cycle. Deoxycholic acid was added to a final concentration of 0.25 % and incubated for 30 minutes at 37°C with shaking. The pH was then lowered to 6.0 with 0.5 M HEPES (pH 5.4) and 5 units of type V neuraminidase (Sigma) was added. This was incubated at 37°C for 1 hour with shaking and the pH was raised back to 7.5 with 0.5 M HEPES (pH 8.0). The sample was then sonicated for 3 x 45 seconds in a water bath before pelleting the cellular debris at 4000 x *g* for 10 minutes. The pellet was resuspended in 5 ml of buffer A and this process was repeated a further two times. The supernatants were combined over a 4 ml 20 % (w/v) sucrose cushion in buffer A before centrifugation at 85,000 x *g* for 3 hours at 4°C in a SW32Ti rotor (Beckman). The pellet was resuspended in 5 ml of 1.34 g/ml CsCl and the isopycnic gradient was spun at 4°C for 16 hours at 110,000 x *g* (no brake) in a SW55Ti rotor (Beckman). The BKV band was collected using a 26-gauge needle and dialysed against 2 L of buffer A (without Triton X-100) for 2 days at 4°C. Dialysis buffer was exchanged twice with pre-chilled buffer A (without Triton X-100).

### Electron Microscopy {#sec4.3.4}

Cryo-EM grids were prepared by applying 3 μl of purified BKV (0.25 mg/ml) to 400 mesh lacey grids coated in a 3 nm carbon film (Agar Scientific, UK). The sample was left to adsorb for 30 seconds before most of the sample was blotted away manually and this process was repeated 4 times. For the reduced BKV structure, 5 mM DTT was added to the sample and incubated for 15 minutes at RT prior to preparing cryo-grids. On-grid binding of receptors was performed by applying 3 μl of a 20 mM solution of GT1b oligosaccharide (CarboSynth) or heparin 10 mg/ml (Sigma -- 4784) in Buffer A (without Triton X-100) to the pre-blotted, BKV-coated grid, and leaving for 30 seconds before blotting and freezing using a Leica EM GP plunge freeze device (Leica Microsystems). The Leica EM chamber temperature was set to 8°C with 80 % relative humidity and liquid ethane was used for sample vitrification. Grids were glow discharged for 30 seconds prior to application of the samples. All data sets were collected on an FEI Titan Krios (ABSL, University of Leeds) transmission electron microscope at 300 kV, at a magnification of 75,000x and a final calibrated object sampling of 1.065 Å/pixel. Exposures were recorded using the EPU automated acquisition software on a FEI Falcon II (unliganded BKV) or Falcon III direct electron detector operating in linear mode. Detailed information on data collection is shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

### Image Processing {#sec4.3.5}

Image processing was carried out using the RELION 2.0 pipeline ([@bib26], [@bib54]). Drift-corrected averages of each movie were created using MOTIONCOR2 ([@bib66]) and the contrast transfer function of each determined using gCTF ([@bib65]). Automated particle picking on lacey carbon grids resulted in a large number of boxes picked on the edges of holes in the carbon film. To remove such 'junk' particles from the data sets, 2D classification in RELION was used with CTF amplitude correction only performed from the first peak of each CTF onwards. Particles were further classified using several rounds of both reference-free 2D classification and 3D classification. After each round, the best classes/class was taken to the next step of classification. Icosahedral symmetry was imposed during 3D auto-refinement and post-processing was employed to appropriately mask the model, estimate and correct for the B-factor of the maps. The final resolutions were determined using the 'gold standard' Fourier shell correlation criterion (FSC = 0.143) shown in [Table S1](#mmc1){ref-type="supplementary-material"}. Local resolution was estimated in RELION which also generated maps filtered by local resolution.

### Model Building and Refinement {#sec4.3.6}

A preliminary model for the BKV asymmetric unit was generated by rigid body fitting our previously published homology model (5FUA) ([@bib22]) into the EM density map using UCSF Chimera ([@bib49]). The model was then manually fitted in Coot using the 'real space refinement tool' ([@bib11]). The resulting model was then symmetrized in Chimera to generate the capsid and subject to refinement in Phenix ([@bib20]). Iterative rounds of manual fitting in Coot and refinement in Phenix were carried out to improve non-ideal rotamers, bond angles and Ramachandran outliers. For VP2, the murine polyomavirus coordinates (1CN3) were aligned to a fivefold coordinated penton of BKV using UCSF Chimera. The VP2 model was then mutated, fitted and refined in Coot before being subject to refinement in Phenix. For GT1b modelling, the coordinates for the oligosaccharide component from the previously determined BKV penton -- GD3 structure ([@bib40]) were used to model the disialic acid motif from the 'right' arm of GT1b. Low-pass filtered maps were generated using RELION image handler and difference maps were generated in UCSF Chimera. Interactions between chains 6 and 3 were analyzed using PDBePISA ([@bib30]). Figures were generated using UCSF Chimera and PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC).

### Molecular Dynamics Simulations {#sec4.3.7}

The x-ray crystal structure 4MJ0 ([@bib40]), was used as a starting structure for MD. Missing protein loops were modelled with YASARA ([@bib29]). The GT1b oligosaccharide was built with AMBER tleap using Glycam06 building blocks ([@bib27]). The glycosidic torsions of the (2-8)-linkage were adjusted to the values found in the x-ray structure for GD3 in site C. GT1b molecules were positioned into the four occupied binding sites by superimposing the terminal Neu5Ac (R) with the terminal Neu5Acs present in the x-ray structure, respectively. An additional 5th GT1b molecule was manually positioned into the remaining binding site resembling the same binding mode. During very long MD simulations, dissociation of ligands can occur, particularly when the binding mode is not optimized at the beginning of the simulation as is the case for 'docked ligands'. Since the binding mode of the terminal Neu5Ac (R) is well established by several H-bonds, distance restraints (Asn-272:OD1-Neu5Ac:N5, Ser-274:OG-Neu5Ac:O1A and Thr-276:OG1-Neu5Ac:O1B) were applied in order to guarantee that this residue stayed in the binding site in a defined binding mode for the whole simulation. A periodic box was filled with a 0.1% NaCl solution, which resulted in a molecular system consisting of 126,430 atoms. The simulations were performed at 310 K with YASARA in 'fast mode' using AMBER14 (which includes Glycam06) as a force field. In total 1.1 μs trajectory data was sampled for the BKV/GT1b pentamer complex distributed over six independent simulations. This allowed analysis of GT1b dynamics in the binding site(s) of BKV over an accumulated time of 5.5 μs. Snapshots were recorded every 50 ps, which gave a trajectory file consisting of 22,200 frames and produced about 20 GByte binary trajectory data in XTC format. All analysis and generation of scientific plots was performed with Conformational Analysis Tools (CAT) - [www.md-simulations.de/CAT/](http://www.md-simulations.de/CAT/){#intref0060}. For calculation of the atom 3D density map all MD frames of the pentamer were superimposed on the EM atomic model using a sequence alignment file. In order to average the density over the five sides the five-fold symmetry was taken into account. Snapshots were visualized with VMD ([@bib21]). Model coordinates are available from the authors upon request.

Quantification and Statistical Analysis {#sec4.4}
---------------------------------------

Where appropriate, statistical details are given in the [Method Details](#sec4.3){ref-type="sec"} section. [Table S1](#mmc1){ref-type="supplementary-material"} contains quantitative parameters related to data collection and image processing.

Data and Software Availability {#sec4.5}
------------------------------

The Cryo-EM maps of BKV-GT1b, BKV-heparin, unliganded-BKV and reduced-BKV reconstructions were deposited in the Electron Microscopy Data Bank under ID codes EMDB 3944, EMDB 3945, EMDB 3946 and EMDB 4212 respectively. The coordinates for the BKV-GT1b asymmetric unit were deposited in the Protein Data Bank under the ID code PDB [6ESB](pdb:6ESB){#intref0065}.
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